<DOC>
	<DOCNO>NCT00042510</DOCNO>
	<brief_summary>This study test whether G17DT Immunogen , administer combination chemotherapy , effective safe treatment gastric cancer .</brief_summary>
	<brief_title>Safety Efficacy G17DT Immunogen Treatment Gastric Gastroesophageal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>Inclusion criterion : Clinical diagnosis gastric gastroesophageal cancer Karnofsky performance status score least 70 Life expectancy least 3 month Exclusion criterion : Prior treatment chemotherapy anticancer immunotherapy Bone marrow transplant within past year Chronic use corticosteroid , except inhaled corticosteroid use asthma chronic obstructive pulmonary disease Central nervous system metastases Immunodeficiency Hypercalcemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Gastroesophageal cancer</keyword>
	<keyword>Gastric cancer</keyword>
</DOC>